Skip to main content
Premium Trial:

Request an Annual Quote

Roche, UCLA Ink Biomarker Research Collaboration

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche said today that it will provide researchers at the University of California, Los Angeles with a range of its genomics tools in a new collaboration to study stem cells and cancer and to develop new targets and biomarkers for disease diagnostics and therapeutics.

Under the agreement, Roche will provide microarray systems from Roche NimbleGen, high-throughput screening tools, genetic expression profilers, and exome sequencing technologies to UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Jonsson Comprehensive Cancer Center.

Roche also will provide UCLA with reagents and technology and bioinformatics support for developing new predictive biomarkers. The firm's scientists also will work collaboratively with the university to develop new tools for both academic and commercial use.

"By working together at an early stage, we can optimize the technologies and provide the necessary support to improve detection and analysis, and ultimately, the success rate of biomarker discovery," Robert Yates, Head of Roche Applied Science, said in a statement.

"Discoveries made by UCLA scientists while working with the technologies will help provide Roche scientists with insight on academic research and can be used to refine Roche operations or develop new applications for the equipment," added Michael Teitell, a Broad and Jonsson center researcher.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.